The exceptional advances in genomic medicine in the last two decades, since the sequencing of the human genome, have already had a major impact on healthcare in the UK. Until recently this was predominantly in secondary and tertiary care, but we must now integrate ‘mainstream’ genomics in primary care. So far integration has of necessity been empirical, but must progress towards implementation research. We describe recent work undertaken by the RCGP and the NIHR CRN outlining areas where research is needed to fully integrate genomics into routine primary care and secure the future of these exciting developments.
Get full access to this article
View all access options for this article.
References
1.
AhlqvistEStormPKäräjämäkiA, et al.(2018) Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables. The Lancet Diabetes and Endocrinology6(5): 361–6. DOI: 10.1016/S2213-8587(18)30051-2.
2.
ArcherSDe VilliersCBScheiblF, et al.(2020) Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study. PLoS ONE15(3): e0229999DOI: 10.1371/journal.pone.0229999.
3.
AttarSGPoustieVJSmyeSW, et al.(2019) Working together to deliver stratified medicine research effectively. British Medical Bulletin129(1): 107–116. DOI: 10.1093/bmb/ldz003.
4.
Case Medical Research (2019) The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. DOI: 10.31525/ct1-nct03857477.
5.
Chase DA, Baron S and Ash JS (2017) Clinical decision support and primary care acceptance of genomic medicine. In: Studies in Health Technology and Informatics 245: 2017. 700-703. DOI: 10.3233/978-1-61499-830-3-700.
De HoogCLMMPortegijsPJMStoffersHEJH (2014) Family history tools for primary care are not ready yet to be implemented. A systematic review. European Journal of General Practice20(2): 125–133. DOI: 10.3109/13814788.2013.840825.
8.
DelvecchioMPastoreCGiordanoP (2020) Treatment options for MODY patients: A systematic review of literature. Diabetes Therapy11: 1667–1685. DOI: 10.1007/s13300-020-00864-4.
9.
Department of Health (2013) The UK Strategy for Rare Diseases, London: HMSO.
10.
DhimanPKaiJHorsfallL, et al.(2014) Availability and quality of coronary heart disease family history in primary care medical records: Implications for cardiovascular risk assessment. PLoS ONE9(1): e81998DOI: 10.1371/journal.pone.0081998.
11.
Eeles RA and ni Raghallaigh H and the BARCODE 1 Study Group (2020) BARCODE 1: A pilot study investigating the use of genetic profiling to identify men in the general population with the highest risk of prostate cancer to invite for targeted screening. Journal of Clinical Oncology 38(15_suppl). American Society of Clinical Oncology: 1505. DOI: 10.1200/JCO.2020.38.15_suppl.1505.
12.
EmeryJDReidGToby PrevostA, et al.(2014) Development and validation of a family history screening questionnaire in Australian primary care. Annals of Family Medicine12(3): 241–249. DOI: 10.1370/afm.1617.
13.
FitzgeraldTWGeretySSHurlesME (2015) Large-scale discovery of novel genetic causes of developmental disorders. Nature519: 223–228. DOI:10.1038/nature14135.
14.
GinsburgGSWuRROrlandoLA (2019) Family health history: Underused for actionable risk assessment. The Lancet394(10198): 596–603. DOI: 10.1016/S0140-6736(19)31275-9.
15.
HortonRCrawfordGFreemanL, et al.(2019) Direct-to-consumer genetic testing. BMJ367: l5688DOI: 10.1136/bmj.l5688.
16.
LeeAMavaddatNWilcoxAN, et al.(2019) BOADICEA: A comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genetics in Medicine21(8): 1708–1718. DOI: 10.1038/s41436-018-0406-9.
17.
LeskoLJZinehIHuangSM (2010) Editorial: What is clinical utility and why should we care?. Clinical Pharmacology and Therapeutics88(6): 729–733. DOI: 10.1038/clpt.2010.229.
18.
ManolioTARowleyRWilliamsMS, et al.(2019) Opportunities, resources, and techniques for implementing genomics in clinical care. The Lancet394(10197): 511–520. DOI: 10.1016/S0140-6736(19)31140-7.
QureshiNArmstrongSDhimanP, et al.(2012) Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: A matched-pair, cluster randomized trial. Annals of Internal Medicine156(4): 253–262. DOI: 10.7326/0003-4819-156-4-201202210-00002.
26.
RafiICrinsonIDawesM, et al.(2020) The implementation of pharmacogenomics into UK general practice: A qualitative study exploring barriers, challenges and opportunities. Journal of Community Genetics11(3): 269–277. DOI: 10.1007/s12687-020-00468-2.
27.
RodenDM, McLeod HLRellingMV, et al.(2019) Pharmacogenomics. The Lancet394(10197): 521–532. DOI: 10.1016/S0140-6736(19)31276-0.
Royal College of Physicians, Royal College of Pathologists and British Society for Genetic Medicine (2019) Consent and confidentiality in genomic medicine: Guidance on the use of genetic and genomic information in the clinic, 3rd edition. Report of the Joint Committee on Genomics in Medicine, London. Available at: www.rcplondon.ac.uk/projects/outputs/consent-and-confidentiality-genomic-medicine (accessed 24 September 2020).
33.
SaundersCLKilianBThompsonDJ, et al.(2020) External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK Biobank. Cancer Prevention Research13: 509–520. DOI: 10.1158/1940-6207.capr-19-0521.
34.
TurnbullCScottRHThomasE, et al.(2018) The 100 000 genomes project: Bringing whole genome sequencing to the NHS. BMJ (Online)361: k1687DOI: 10.1136/bmj.k1687.
35.
VorderstrasseAAChoAVoilsCI, et al.(2013) Clinical utility of genetic risk testing in primary care: The example of type 2 diabetes. Personalized Medicine10(6): 549–563. DOI: 10.2217/pme.13.47.
36.
WalterFMEmeryJD (2012) Genetic advances in medicine: Has the promise been fulfilled in general practice?. British Journal of General Practice62(596): 120–121. DOI: 10.3399/bjgp12X629955.
37.
WalterFMPrevostATBirtL, et al.(2013) Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. British Journal of General Practice63(611): e393–400. DOI: 10.3399/bjgp13X668186.
38.
WengSKaiJTranterJ, et al.(2018) Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study. Atherosclerosis274: 54–60. DOI: 10.1016/j.atherosclerosis.2018.04.037.
39.
WengSFKaiJAndrew NeilH, et al.(2015) Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis238(2): 336–343. DOI: 10.1016/j.atherosclerosis.2014.12.034.
40.
WilsonBJQureshiNSantaguidaP, et al.(2009) Systematic review: Family history in risk assessment for common diseases. Annals of Internal Medicine151(12): 878–885. DOI: 10.7326/0003-4819-151-12-200912150-00177.
